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Abstract: Delving deeper is possible in whole body in vivo imaging 
using a super-bright membrane targeting BODIPY dye (BD).  The dye 
was employed to monitor homing of ex vivo, fluorescently labelled 
neutrophils to an injured liver of dark pigmented C57BL/6 mice. In 
Vivo Imaging System (IVIS) data conclusively showed an enhanced 
signal intensity and a higher signal-to-noise ratio in mice receiving 
neutrophils labelled with the BD dye compared to those labelled with 
a gold standard dye at 2 hr post in vivo administration of fluorescently 
labelled cells. Fluorescence-activated cell sorting (FACS) confirmed 
that BD was non-toxic, and an exceptional cell labelling dye that 
opens up precision deep organ in vivo imaging of inflammation in mice 
routinely used for biomedical research. The origin of enhanced 
performance is identified with the molecular structure, and the distinct 
localisation of the dye within cells that enable remarkable changes in 
its optical parameters. 
Chronic liver disease is prevalent in many developed countries 
and the incidence of disease is rising year-on-year due to viral 
infection, alcohol consumption and the obesity epidemic.[1] In 
response to liver damage, immune cells are recruited to the site 
of injury and initiate wound repair. In chronic disease, 
inflammation and scar cells persist, causing fibrosis and 
eventually organ failure.[2] More generally, inflammation is a key 
driver of chronic disease, cancer and is a feature of ageing.[3] 
Whilst we validate use of the BD dye to monitor damage-induced 
hepatic inflammation, this methodology is readily transferable and 
can be exploited to monitor inflammation in any organ during 
acute or chronic disease. Developing techniques that help 
illuminate inflammatory processes will ultimately advance our 
understanding of disease pathology and provide tools to assess 
treatment response.[4] An emerging technology is focused on 
optical recording using an In Vivo Imaging System (IVIS)[5] 
combined with direct labelling of cells with a lipophilic fluorescent 
dye; it is frequently used to longitudinally track cells to study 
disease biology[6] and test new drugs within a whole animal.[7]  The 
applications of IVIS include: (i) the monitoring inflammation and 
recruitment of immune cells to a site of injury,[8] (ii) visualization of 
immune cell:tumour interactions[9] and (iii) the assessment of the 
biodistribution and migration of cell-based therapies.[10]  
Whole body minimally-invasive imaging provides spatial and 
temporal information that can provide a better understanding of 
cell behavior,[11] or monitor a therapeutic response in the native 
environment.[12] Moreover, high-resolution molecular imaging of 
fluorescent labelled cells in vivo is also feasible through optical 
windows surgically implanted into the skin of mice to view an 
organ with fluorescence microscopes.[13] A limitation of 
fluorescence-based IVIS imaging is that many employed 
fluorescent dyes are often not tailor-made for a specific purpose, 
fluoresce within the autofluorescence range (ca., 450-560 nm), 
are not sufficiently bright to penetrate tissue, rapidly photobleach, 
have broad excitation and emission spectra which restricts 
multiplex imaging capabilities or are cytotoxic.[14] The cyanine dye 
CellVue Burgundy 710 CD (Figure 1) is generally recognized as 
a gold standard lipophilic dye for cell membrane labelling, and is 
frequently used in conjunction with IVIS for in vivo cell tracking.[15]  
 
Figure 1. Chemical structure of the NIR fluorescent derivative BD used in IVIS 
along with the core structure of the common dye CellVue Burgundy 710 (CD) 
used for cell tracking. Note: X and Y are heteroatoms to tune the photophysical 
properties of the dye. 
Although CD is used in in vivo cell monitoring its application is 
often limited to nude or albino mice and/or in disease models 
where pathology is superficially localized (i.e., skin).[16] Nude and 
albino mice do not develop skin pigmentation and provide a level 
of tissue transparency, leading to enhanced photon penetrance. 
C57Bl/6 mice are the preferred strain for preclinical mouse 
models because the majority of transgenic mice are generated on 
this background, and unlike nude mice, which lack T-
cells, C57Bl/6 mice have a normal immune system. In medical 
research it is essential to study disease in orthotopic mouse 
models. The liver is a deep-seated organ and tissue depth 
provides a major barrier in signal detection. To overcome this 
technical challenge it is important to develop fluorophores that 
emit in the near infrared range (> 700 nm) and are compatible with 
other fluorescent imaging technologies (e.g., FACS), which allow 
validation of in vivo data at the cellular level. In our line of research 
into producing optically responsive neuron firing probes the 
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neutral Bodipy derivative BD (Figure 1) was developed.[17] As part 
of these studies it was noted that BD localized strongly in 
membranes with intense fluorescence in the near-infrared 
region.[18] Perceiving the potential for BD to track inflammatory 
cells using an IVIS to monitor acute liver damage, the dye was 
directly compared with the CD under identical conditions; BD 
outperforms CD in brightness and importantly, does not cause cell 
apoptosis. The basic dye structure also lends itself more easily to 
fine-tuning of emission characteristics, and secondary group 
attachment (e.g., antibodies) via the aryl groups.           
 
 
Figure 2. Room-temperature normalised UV/Vis-NIR absorption and emission 
spectra for compounds BD (solid line) and CD (dotted line) in cyclohexane. 
Excitation spectra are shown with open circles. 
Absorption and fluorescence spectra for BD are shown in Figure 
2. The long-wavelength absorption profile consists of a strong and 
narrow absorption band at 623 nm with a large broader 
appearance as a higher energy tail. To the low-energy side it can 
be noticed that the band does not exactly follow the Gaussian 
shape, and there is a tail stretching into the far-red region. This 
observation can be understood by looking at the frontier molecular 
orbitals (Figure 3). While HOMO and LUMO are mostly localized 
on the extended BODIPY core, the HOMO-1 is located 
preferentially on the julolidine unit. Thus, the lowest energy 
transition can be attributed to the BODIPY π-π* transition and the 
HOMO-1 to LUMO transition can be crudely described as a 
julolidine-BODIPY charge transfer transition. A TD-DFT 
calculation in cyclohexane predicts the energy of the two 
transitions to be 2.12 eV and 2.14 eV, respectively, so essentially 
a significant overlap of the two bands is expected (see Supporting 
Information). Deconvolution of the absorption profile into a series 
of Gaussians requires the use of three typical BODIPY bands and 
an additional broader band (Supporting Information). The two 
transitions are close in energy 624 nm and 566 nm respectively, 
in agreement with the TD-DFT results. The emission profile shows 
a band at 630 nm with a small Stokes shift, and is not the exact 
mirror image of the absorption spectrum due to the missing broad 
charge-transfer band. The excitation profile mostly mirrors the 
absorption spectrum except for the lower intensity of the high-
energy shoulder, in line with the presence of a non-emissive 
excited state. The quantum yield of fluorescence (FLU) in 
cyclohexane is 0.75 with a fluorescence lifetime (S) of 4.3 ns 
(Supporting Information). Fluorescence is partially quenched as 
the solvent polarity is increased because of stabilization of the 
charge transfer state, leading to a new non-radiative excited state 
decay pathway. The FLU for BD and CD in the membrane-like 
solvent oleic acid are 0.64 and 0.43, respectively. Given the 
higher molar absorption coefficient of BD (40,000 M-1 cm-1) with 
respect to CD (22,000 M-1 cm-1), one might expect its brightness 
to be ca. 2.7 times greater.[19]       
 
Figure 3. Representation of the Gaussian calculated Kohn–Sham frontier 
molecular orbitals for BD in cyclohexane using an IEF-PCM model at 
mPW1PW91/6-311+G(d,p) theoretical level.[20]  
 
Figure 4. Room-temperature emission spectra for BD in oleic acid (black dotted 
line), 15 mM Triton X-100 solution in water (red solid line) and neutrophils cells 
in PBS buffer (red dots). 
The emission profile of neutrophil cells in PBS stained with BD is 
dominated by a band at 670 nm, red-shifted and broadened as 
compared with the solution spectrum in oleic acid with relatively 
similar physical parameters compared to a cell membrane (Figure 
4). This observation cannot be explained by stabilization of the 
excited state in an environment of a higher polarity as there are 
only marginal changes to the emission maxima when measured 
in the highly polar DMSO solvent. The broadening and redshift to 
653 nm is repeated for the emission from micelles of Triton X-100 
in water. This is indicative of selective positioning of the dye at the 
lipid-water interface that leads to a non-uniform solvation 
environment around the molecule, affecting the bandgap energy 
and hence to emission profile broadening. The redshift is 
attributed to a better stabilization of the excited state by the dual 
nature of the bilayer. From the point of view of fluorescence 
microscopy this shifts the signal of interest into the optical window 
of biological tissue. Emission from the dye exterior to cells is 
preferentially absorbed by tissue material, making BD a prime 
candidate for cells labelling and bioimaging purposes.[21]  
 
To prove the potential of BD for the bioimaging of neutrophils, an 
immune cell subtype was labelled with BD and CD using an 
identical protocol already widely accepted in IVIS experiments.[22] 
Wild type C57BL/6 mice were administered a single 
intraperitoneal dose of carbon tetrachloride (CCl4) to cause liver 
injury. 24 h post liver damage, recipient mice were injected 
intravenously with 10 million labelled neutrophils. The majority of 
HOMO-1 (-5.35 eV)HOMO (-5.27 eV)
LUMO (-2.98 eV) LUMO+1 (-1.60 eV)
  
the neutrophils home to the liver in this model and are known to 
generally locate adjacent to the areas of injury surrounding the 
central vein regions and are distributed homogeneously across 
the different liver lobes.  2 h post cell administration whole body 
in vivo IVIS was used to monitor recruitment of fluorescently 
labelled neutrophils to the injured liver of mice. In vivo fluorescent 
signal was quantified by drawing region of interest (ROI) in the 
area where the liver is localised. Figure 5 shows the IVIS images 
of mice injected with CD or BD labelled neutrophils. The 
fluorescent overlay is observed in the upper quadrant of the 
abdominal area where the liver is situated. Compared to CD, BD 
labelled neutrophils provide significantly higher radiant efficiency, 
suggesting that BD is brighter and more readily detectable by IVIS. 
Although IVIS allows whole body imaging, signal to noise ratio is 
limited by tissue depth, but this study found that BD provided 
enhanced signal detection and photon penetration depth.  BD can 
facilitate in vivo imaging of various biological processes in deep-
seated organs without the need to sacrifice the animals. 
 
 
Figure 5. IVIS imaging of neutrophils labelled with CD or BD, tracking to the 
liver of mice with acute liver injury. IVIS images of mice (top) and ex vivo imaged 
livers (bottom) and graph showing the fluorescence signal as total radiant 
efficiency. Total radiant efficiency is mean ± s.e.m, n = 4 recipient mice/ group. 
Statistical significance was determined using an unpaired t-test, *P < 0.05. 
Figure 6. FACS plots showing comparison of ex vivo labelled murine 
neutrophils with CD and BD. (live/dead cells are circled). Right FACS plot 
showing the comparative brightness in log scale of BD compared to CD. 
 
To validate that the in vivo signal originated from the liver, mice 
were humanely killed, and the liver excised and then ex vivo 
imaged on the IVIS (Figure 5). A similar bright fluorescence signal 
was observed for the ex vivo images, the signal detection was 
significantly higher in the liver of mice injected with BD labelled 
neutrophils compared to those labelled with CD. Our data shows 
that BD is far superior to CD for the application of non-invasive, 
whole body fluorescence cell-tracking. The enriched intense 
fluorescence of BD offers a clear advantage of detecting a 
reduced number of cells, thus increasing the sensitivity of the 
technique in detecting smaller areas of interest. BD provides an 
ideal tool to monitor cell infiltration in deep-seated organs of wild 
type mice, as it overcomes the main challenges associated with 
in vivo optical imaging, such as tissue depth and black skin 
pigmentation. This methodology is not limited to studying 
damage-induced hepatic inflammation, but can be adapted to 
various orthotopic mouse models. A significant advantage of BD 
is that it can be applied to various genetic mouse models 
generated on the C57bl/6 background.  
 
Fluorescence-activated cell sorting (FACS) methodology was 
used to separate the fluorescently labelled neutrophils recruited 
to the injured liver, based on their spectral signature compared to 
other unlabeled liver cells. A very low cytotoxicity was found for 
both dyes, with only 1.6 % dead cells for CD and a marginal 
improvement of 1.4 % for BD (Figure 6). Furthermore, FACS was 
also applied to assess fluorescent signal intensity. A log plot of 
comparative brightness proves BD provides an order of 
magnitude more intense emission signal (Figure 6). This supports 
once again the superiority of the dye in labeling neutrophil cells 
for imaging purposes.  
 
In conclusion, the unique properties of BD have been used to 
open new possibilities for the in vivo imaging technique.[23] The 
unusually strong red-shift of the emission from the neutrophils 
allowed for significantly brighter signals in all the attempted 
experiments, and more importantly during the whole body IVIS 
imaging of CCl4 injured liver of mice with BD labelled neutrophils. 
The enhanced signal-to-noise ratio and low cytotoxicity allows 
performing the previously inaccessible fine-imaging experiments 
on live specimens. The dye also allows imaging of fewer cells, 
currently a limiting factor for IVIS cell tracking, because of the 
lower detection limit possible in terms of the numbers of cells that 
can be identified. Given the enhanced brightness and narrow 
excitation profile of BD we are currently investigating its use in 
concomitantly identifying more than one cell type by multiplex 
spectral imaging. 
  
Experimental Section 
All chemicals were purchased from commercial sources and used 
as received unless otherwise stated. Solvents for spectroscopic 
investigations were of the highest purity available. The title 
compound BD was available from previous studies[17] and purified 
by column chromatography before use and its purity checked by 
NMR spectroscopy. Quantum yields of fluorescence were 
measured by the comparison method using AzaBODIPY (5,5-
difluoro-3,7-bis(4-methoxyphenyl)-1,9-5H-4dipyrrolo[1,2-
c:2’,1-f[1,3,5,2]triazaborinine).[24] Selected data are shown in 
Table S1. 
 
Computational calculations were performed using a 32-bit version 
of Gaussian09 on a quadruple-core Intel Xeon system with 4GB 
RAM. The calculations were run in parallel, fully utilising the multi-
core processor. Firstly, the structure of BD was optimised with the 
DFT mPW1PW91/3-21G method and the result was used as the 
input for calculations at the mPW1PW91/6-311+G(d,p) without 
any symmetry constraint in cyclohexane solvent using an IEF-
PCM model. Energy minimization calculations were monitored 
using the programme Molden and run in parallel with frequency 
calculations to ensure optimized geometries represented local 
minima. The electronic transitions of BD were calculated using 
IEF-PCM solvent model at mPW1PW91/6-311+G(d,p) theory 
level.  
 
Electronic absorption spectra were recorded at RT using a 
Shimadzu UV-1800 spectrophotometer. Fluorescence emission 
spectra were acquired at RT with a Shimadzu RF-6000 
fluorimeter. Fluorescence lifetimes were collected using a PTI 
EasyLife apparatus. Spectra deconvolution was performed using 
PeakFit software. IVIS experiements were carried out using a 
Perkin Elmer IVIS Spectrum in-vivo imaging system and 
neutrophils were imaged using a BD LSRFortessa™ X-20 (BD 
Biosciences) system. Data analysis was achieved using flowjo 
V10 software. 
 
All experiments on mice were performed under approval from the 
Newcastle Ethical Review Committee and a UK Home Office 
licence. Prior to in-vivo fluorescence imaging neutrophils were 
labelled with either the BODIPY-based dye (BD) or the 
commercially available CellVue Burgundy 710 dye (CD) 
according to manufacture instructions. The concentration of the 
dye stock solution = 1mM in ethanol and the final neutrophil 
labelling concentration = 2 μM. The labelling time = 4 minutes.  
 
Following successful cell labelling, CCl4 injured mice were 
intravenously (IV) injected with 10 million fluorescently labelled 
neutrophils. 2 h post IV injection mice were anaesthetised under 
isoflurane and IVIS imaged using an excitation filter of 675 nm 
and an emission filter of 720 nm. After the final in-vivo scan mice 
were sacrificed and the livers were harvested for ex-vivo imaging 
using the same filter set as above.  
 
The average radiant efficiency [p/s/cm2/sr]/[μW/cm2] for both in-
vivo and ex-vivo images was analysed using Living Image 4.4 
software. In-vivo scans were analysed by drawing regions of 
interest (ROI) in the upper quadrant of the abdomen, below the 
sternum to the middle of the abdominal region, where the liver is 
anatomically situated. Ex-vivo fluorescent signal was quantified 
by drawing triangular ROIs to encapsulate the liver.  
 
Fluorescence confocal imaging was performed using murine 
neutrophils labelled with BD dye and fixed in 4% PFA in PBS for 
20 minutes and then counterstained with DAPI. Confocal 
fluorescent images were taken using a Zeiss 
AxioImager upright microscope using Cy5 and DAPI filters.  
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